Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-28 Sale |
2023-02-27 9:15 pm |
CinCor Pharma Inc. | CINC | HEALY JAMES Katabi Maha Sofinnova Management X L.P. Sofinnova Management X-A L.L.C. Sofinnova Venture Partners X L.P. Director 10% Owner |
25,608 | $3.3552 | $85,920 | 0 (Indirect Direct) |
View |
| 2023-02-06 Purchase |
2023-02-08 6:29 pm |
Vera Therapeutics Inc. | VERA | Sofinnova Venture Partners X L.P. Sofinnova Management X L.P. HEALY JAMES Katabi Maha Sofinnova Management X-A L.L.C. 10% Owner |
285,714 | $7 | $1,999,998 | 3,467,156 (Direct) |
View |
| 2022-08-11 Purchase |
2022-08-15 3:46 pm |
CinCor Pharma Inc. | CINC | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha 10% Owner |
500,000 | $30 | $15,000,000 | 6,073,949 (Indirect) |
View |
| 2022-02-10 Purchase |
2022-02-14 6:17 pm |
Vera Therapeutics Inc. | VERA | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha 10% Owner |
266,666 | $15 | $3,999,990 | 3,181,442 (Direct) |
View |
| 2022-01-11 Purchase |
2022-01-13 4:38 pm |
CinCor Pharma Inc. | CINC | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha 10% Owner |
325,000 | $16 | $5,200,000 | 5,573,949 (Indirect) |
View |
| 2021-07-02 Purchase |
2021-07-06 4:28 pm |
Aerovate Therapeutics Inc. | AVTE | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES 10% Owner |
357,142 | $14 | $4,999,988 | 3,758,686 (Direct) |
View |
| 2021-05-18 Purchase |
2021-05-18 8:23 pm |
Vera Therapeutics Inc. | VERA | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner |
727,272 | $11 | $7,999,992 | 2,914,776 (Direct) |
View |
| 2021-02-09 Purchase |
2021-02-09 6:04 pm |
Bolt Biotherapeutics Inc. | BOLT | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha POWELL MICHAEL 10% Owner |
450,000 | $20 | $9,000,000 | 2,754,437 (Direct) |
View |
| 2020-07-28 Purchase |
2020-07-28 6:08 pm |
Inozyme Pharma Inc. | INZY | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner |
437,500 | $16 | $7,000,000 | 2,028,308 (Direct) |
View |
| 2020-06-30 Purchase |
2020-07-01 9:36 pm |
Akouos Inc. | AKUS | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner |
58,823 | $17 | $999,991 | 1,515,073 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-24 Equity Swap |
2023-02-27 9:15 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | HEALY JAMES Katabi Maha Sofinnova Management X L.P. Sofinnova Management X-A L.L.C. Sofinnova Venture Partners X L.P. Director 10% Owner |
6,083,752 | $0 | 0 (Direct) |
View |
| 2022-01-11 Conversion |
2022-01-13 4:38 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha 10% Owner |
23,095,377 | $0 | 5,573,949 (Indirect) |
View |
Ownership |
2022-01-06 8:54 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | Sofinnova Venture Partners X L.P. Katabi Maha Sofinnova Management X L.L.C. 10% Owner |
0 | $0 | 5,248,949 (Indirect) |
View |
| 2021-07-02 Conversion |
2021-07-06 4:28 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES 10% Owner |
13,966,782 | $0 | 3,758,686 (Direct) |
View |
Ownership |
2021-06-29 7:43 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES 10% Owner |
0 | $0 | 3,401,544 (Direct) |
View |
| 2021-05-18 Conversion |
2021-05-18 8:23 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner |
2,187,504 | $0 | 2,914,776 (Direct) |
View |
Ownership |
2021-05-13 7:30 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner |
0 | $0 | 2,187,504 (Direct) |
View |
| 2021-02-09 Conversion |
2021-02-09 6:04 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha POWELL MICHAEL 10% Owner |
2,304,437 | $0 | 2,754,437 (Direct) |
View |
Ownership |
2021-02-04 8:59 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha POWELL MICHAEL 10% Owner |
0 | $0 | 2,304,437 (Direct) |
View |
| 2020-07-28 Conversion |
2020-07-28 6:08 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner |
13,478,920 | $0 | 2,028,308 (Direct) |
View |
Ownership |
2020-07-23 9:31 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL Katabi Maha 10% Owner |
0 | $0 | 1,590,808 (Direct) |
View |
| 2020-06-30 Conversion |
2020-07-01 9:36 pm |
N/A N/A |
Akouos Inc. | AKUS | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner |
32,143,835 | $0 | 1,515,073 (Direct) |
View |
Ownership |
2020-06-25 9:26 pm |
N/A N/A |
Akouos Inc. | AKUS | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner |
0 | $0 | 1,456,250 (Direct) |
View |